Share on (60686060226):

Glycometabolism Items | |||||
NO |
Short Name | Specification |
Package(ml) |
Abb. |
Method |
70129 | Glucose | R:60mL×2 | 120ml | GLU | Oxidase Method |
70130 | Glucose | R1:64ml×2 R2:16ml×2 | 160ml | GLU | HK Method |
70131 | Saccharify Haemocyanin | R:60mL×2 | 120ml | GSP | Two Points Method |
70158 | Saccharify Gemoglobin | R1a:35mL×1 R1b:15mL×1 R2:23mL×1 R3:70mL×1 | 143ml | HbA1c | Enzymatic Assay Method |
70159 | D3 Hydroxybutyric Acid | R1:60ml×2 R2:20ml×2 | 160ml | D3H | Enzymatic Assay Method |
70160 | Lactic Acid | R1:60ml×2 R2:20ml×2 | 160ml | LAC | Enzyme Development Process |
70197 | Saccharify Gemoglobin | R1: 60ml×1 R2a: 1ml×1 R2b: 19ml×1 | 80ml | HbA1c | Latex enhanced immune turbidimetry |
[NAME]
Name:Glucose (GLU) Test Kit (Hexokinase)
[Package]
R1:64mL×2 R2:16mL×2 R1:20mL×4 R2:5mL×4
R1:20mL×1 R2:5mL×1 R1:80mL×1 R2:20mL×1
R1:40mL×4 R2:20mL×2 R1:48mL×2 R2:12mL×2
R1:80mL×2 R2:20mL×2 R1:48mL×2 R2:24mL×1
R1:100mL×1 R2:25 mL×1
2×200Tests
[INTENDE USE]
The reagent is intended for the in vitro quantitative determination ofGlucose(GLU) in human serum,plasma on both manual and automated systems.
[METHODOLOGY]
HK
Glucose + ATP Glucose -6- phosphate + ADP
G6P-DH
Glucose -6- phosphate + NAD+ Glucose 6- phosphate acid+ NADH + H+
ATP:Adenosine three phosphate
HK:Hexokinase
G6P-DH:Glucose -6- phosphate dehydrogenase
[REAGENT COMPOSITION]
Reagent 1(R1):
Tris buffer 80mmol/L
Mg2+ 4mmol/L
Adenosine three phosphate(ATP) 1.7mmol/L
NAD+ 1.7mmol/L
Reagent 2(R2):
Tris buffer 80mmol/L
Mg2+ 4mmol/L
Hexokinase(HK) ≥1500U/L
Glucose -6- phosphate dehydrogenase(G6P-DH) ≥1500U/L
[STABILITY AND STORAGE]
Unopened, avoid light preservation in 2 ~ 8 ℃, valid for 12 months;
Opened, avoid light preservation in 2 ~ 8 ℃, valid for 1 month.
Reagent is not allowed frozen.
[SPECIMEN COLLECTION AND HANDLING]
Serum, heparin anticoagulant blood plasma.
Plasma should be separation in 1 hours after the blood was collected.
Specimens can not be repeated freezing and thawing. Do not use contaminated specimens.
When the ascorbic acid concentration of sample≤1704μmol/L;bilirubin concentrations≤684μmol/L,hemoglobin hemoglobin≤5.00g/L, triglyceride concentrations≤22.6 mmol/L, was not observed clearly disturbance.
[APPLICABLE INSTRUMENT]
[TESTING SPECIFICATION]
Wavelength/sub wavelength 340nm/450nm
Cuvette light path 1.0cm
Temperature 37℃
Assay Type End-point


Founded in 1999, having over 2000 employees (till August, 2018), BIOBASE Group is a new high-tech enterprise focusing on development, production and management of scientific equipment, In Vitro Diagnosis (IVD) instrument and reagent.
BIOBASE Group is specialized in products of 8 areas including medical diagnosis, biosafety protection, disinfection and sterilization, water purification system, infant care products, cold chain products, software products, clean room project.
Gathering up a professional team of experts, scholars as well as other scientific research personnels, our company has obtained patents and expanded marketing for multiple products such as the self-developed Biochemistry analyzer, 107 kinds of Reagents, Automatic Elisa processor, Medical sterilization instrument and Biosafety protection equipment.
BIOBASE Group have completed the construction of BIOBASE first industrial park in Zhangqiu, covering an area of 80,000 square meters, second industrial park in Tangye new district, covering an area of 160,000 square meters, and USA incubator in Silicon valley, covering an area of 2000 square meters.
BIOBASE Group has set up branch offices in 24 provinces in China, and has also set up warehouses in the United States, India, Jordan, Germany and Spain. We now have long-term business partners in more than 130 countries.
BIOBASE Group always adheres to the mission of “service for health for the future” and promotes company’s culture vigorously. Providing with high quality products and good service, BIOBASE would like to establish win-win business cooperation with distributors all over the world.


New products from manufacturers at wholesale prices